Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421 (Q24805756)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421	scientific article

Statements

scholarly article

0 references

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421 (English)

0 references

author name string

Thomas W Meade

1

0 references

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 July 2001

0 references

Current controlled trials in cardiovascular medicine

1 reference

2

0 references

4

0 references

195-204

0 references

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

7 April 2017

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

7 April 2017

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

7 April 2017

Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 September 2017

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 September 2017

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 September 2017

Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

30 May 2018

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

30 May 2018

Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

30 May 2018

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 November 2018

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 November 2018

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 November 2018

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen polymorphisms are not associated with the risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solid phase radioimmunoassays for human C-reactive protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen after coronary angioplasty as a risk factor for restenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cerebral blood flow in response to changes in blood viscosity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implication of fibrate therapy for homocysteine

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/CVM-2-4-195

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24805756&oldid=2176979788"